NFKB1 and Insulin resistance: NF-κB signaling and consequent additional production of pro-inflammatory mediators in liver contribute to insulin resistance in the early stages of T2D, whereas activation of NF-κB in adipose tissue M1-macrophages expedites dissemination of circulating inflammatory mediators, promoting systemic insulin resistance in muscle and other insulin-sensitive tissues [9].